NuVasive® is an innovative medical device company focused on developing minimally disruptive surgical products and procedures for the spine. Our mission is to improve the lives of patients who suffer from debilitating back, neck, or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery through focusing on Speed of Innovation®, Absolute Responsiveness®, and superior clinical results.
Through innovative technological advancements, NuVasive has successfully progressed major spine surgery into the realm of outpatient surgery. Many patients have experienced extraordinary results—they are often walking the same day of surgery, suffering less blood loss, spending less time in the hospital, and are back to work within four to six weeks (versus six months).
NuVasive offers more than 65 products spanning lumbar, thoracic, and cervical applications, as well as a portfolio of biologics. Our products have been used in hundreds of thousands of spine surgeries. NuVasive is the fourth-largest spine company in the U.S., and the fifth-largest globally.
NuVasive had revenue of $500 million in 2010 and employs more than 1,100 people. Corporate headquarters are in San Diego, California and additional offices are in Memphis, Tennessee and Paramus, New Jersey; as well as Puerto Rico, the United Kingdom, Germany, Australia, Singapore, and Japan.